Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoma, Osteoid | 14 | 2016 | 90 | 2.510 |
Why?
|
Radiology | 15 | 2024 | 2102 | 1.690 |
Why?
|
Bone Neoplasms | 22 | 2019 | 2531 | 1.660 |
Why?
|
Radiology Department, Hospital | 6 | 2017 | 405 | 1.160 |
Why?
|
Chordoma | 5 | 2017 | 346 | 1.100 |
Why?
|
Radiology Information Systems | 8 | 2018 | 528 | 1.090 |
Why?
|
Lumbar Vertebrae | 8 | 2020 | 1868 | 0.980 |
Why?
|
Musculoskeletal System | 3 | 2016 | 181 | 0.880 |
Why?
|
Spinal Neoplasms | 4 | 2017 | 716 | 0.820 |
Why?
|
Periodicals as Topic | 5 | 2016 | 1462 | 0.820 |
Why?
|
Radiography, Interventional | 6 | 2015 | 1112 | 0.810 |
Why?
|
Gaucher Disease | 4 | 2014 | 110 | 0.800 |
Why?
|
Catheter Ablation | 12 | 2016 | 2740 | 0.730 |
Why?
|
Diagnostic Imaging | 9 | 2019 | 3526 | 0.650 |
Why?
|
Pyrrolidines | 3 | 2014 | 337 | 0.560 |
Why?
|
Lipomatosis | 1 | 2016 | 112 | 0.510 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2016 | 117 | 0.510 |
Why?
|
Tomography, X-Ray Computed | 25 | 2020 | 20500 | 0.500 |
Why?
|
Publishing | 2 | 2016 | 833 | 0.490 |
Why?
|
Magnetic Resonance Imaging | 22 | 2019 | 36284 | 0.490 |
Why?
|
Medical Records | 2 | 2011 | 1406 | 0.480 |
Why?
|
Bone Demineralization, Pathologic | 1 | 2014 | 7 | 0.480 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 248 | 0.480 |
Why?
|
Spinal Diseases | 3 | 2018 | 559 | 0.460 |
Why?
|
Extremities | 4 | 2013 | 865 | 0.450 |
Why?
|
Radiography | 8 | 2021 | 6954 | 0.450 |
Why?
|
Hospital Information Systems | 1 | 2015 | 393 | 0.430 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2017 | 586 | 0.420 |
Why?
|
Workflow | 1 | 2017 | 850 | 0.400 |
Why?
|
Child Abuse | 1 | 2021 | 1068 | 0.400 |
Why?
|
Automation | 2 | 2011 | 580 | 0.400 |
Why?
|
Tibia | 3 | 2014 | 1065 | 0.390 |
Why?
|
Lumbosacral Region | 4 | 2017 | 291 | 0.380 |
Why?
|
Medical Order Entry Systems | 5 | 2016 | 522 | 0.370 |
Why?
|
Thoracoscopy | 1 | 2011 | 176 | 0.370 |
Why?
|
Waiting Lists | 1 | 2015 | 762 | 0.360 |
Why?
|
Journal Impact Factor | 1 | 2012 | 153 | 0.360 |
Why?
|
Thoracic Vertebrae | 2 | 2011 | 596 | 0.350 |
Why?
|
Spine | 2 | 2017 | 1111 | 0.350 |
Why?
|
Curriculum | 1 | 2024 | 3717 | 0.350 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2012 | 187 | 0.350 |
Why?
|
Spinal Fractures | 1 | 2016 | 702 | 0.340 |
Why?
|
Editorial Policies | 1 | 2014 | 456 | 0.340 |
Why?
|
Fluoroscopy | 2 | 2010 | 944 | 0.340 |
Why?
|
Low Back Pain | 1 | 2018 | 979 | 0.330 |
Why?
|
Academic Medical Centers | 2 | 2019 | 2751 | 0.330 |
Why?
|
Quality Assurance, Health Care | 6 | 2016 | 2167 | 0.320 |
Why?
|
Sacrum | 4 | 2016 | 277 | 0.310 |
Why?
|
Durapatite | 1 | 2010 | 163 | 0.310 |
Why?
|
Decision Support Systems, Clinical | 5 | 2016 | 1162 | 0.310 |
Why?
|
Enzyme Inhibitors | 3 | 2014 | 3709 | 0.300 |
Why?
|
Lipodystrophy, Congenital Generalized | 1 | 2007 | 10 | 0.300 |
Why?
|
Cosmetic Techniques | 1 | 2010 | 148 | 0.300 |
Why?
|
Electronic Mail | 1 | 2009 | 213 | 0.290 |
Why?
|
Radiographic Image Enhancement | 1 | 2012 | 875 | 0.290 |
Why?
|
Radiography, Thoracic | 2 | 2012 | 1296 | 0.290 |
Why?
|
Cartilage Diseases | 1 | 2008 | 156 | 0.280 |
Why?
|
Connective Tissue Diseases | 1 | 2010 | 285 | 0.270 |
Why?
|
Bone Density | 3 | 2014 | 3533 | 0.270 |
Why?
|
Biopsy | 5 | 2019 | 6768 | 0.270 |
Why?
|
Arm Bones | 1 | 2006 | 4 | 0.270 |
Why?
|
Internet | 2 | 2010 | 3082 | 0.270 |
Why?
|
User-Computer Interface | 4 | 2018 | 1397 | 0.270 |
Why?
|
Musculoskeletal Diseases | 1 | 2011 | 595 | 0.250 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2016 | 9273 | 0.250 |
Why?
|
Diabetic Foot | 1 | 2009 | 380 | 0.250 |
Why?
|
Peer Review, Health Care | 2 | 2016 | 73 | 0.240 |
Why?
|
Scapula | 1 | 2006 | 173 | 0.230 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2005 | 146 | 0.230 |
Why?
|
Humans | 89 | 2024 | 758406 | 0.230 |
Why?
|
Adrenal Cortex Hormones | 2 | 2012 | 1870 | 0.220 |
Why?
|
Osteomyelitis | 2 | 2020 | 407 | 0.200 |
Why?
|
Radiation Dosage | 1 | 2010 | 1956 | 0.200 |
Why?
|
Anti-Anxiety Agents | 4 | 2007 | 397 | 0.200 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2003 | 188 | 0.200 |
Why?
|
Outpatients | 4 | 2017 | 1591 | 0.190 |
Why?
|
Anesthetics, Local | 1 | 2008 | 1000 | 0.190 |
Why?
|
Referral and Consultation | 5 | 2016 | 3586 | 0.190 |
Why?
|
Glucosylceramidase | 1 | 2002 | 125 | 0.190 |
Why?
|
Cartilage, Articular | 1 | 2008 | 1091 | 0.190 |
Why?
|
Calcinosis | 1 | 2010 | 1467 | 0.190 |
Why?
|
Models, Statistical | 1 | 2015 | 5070 | 0.180 |
Why?
|
Chi-Square Distribution | 4 | 2012 | 3425 | 0.180 |
Why?
|
Sarcoma | 4 | 2016 | 1785 | 0.180 |
Why?
|
Biopsy, Needle | 3 | 2015 | 1630 | 0.180 |
Why?
|
Discitis | 1 | 2020 | 45 | 0.180 |
Why?
|
Adult | 36 | 2019 | 219935 | 0.170 |
Why?
|
Clinical Competence | 3 | 2024 | 4775 | 0.160 |
Why?
|
Osteoblastoma | 1 | 2019 | 24 | 0.160 |
Why?
|
Male | 48 | 2020 | 358747 | 0.160 |
Why?
|
Diagnostic Errors | 2 | 2016 | 1263 | 0.160 |
Why?
|
Soft Tissue Neoplasms | 3 | 2015 | 1152 | 0.160 |
Why?
|
Middle Aged | 34 | 2018 | 219568 | 0.150 |
Why?
|
Femoral Fractures | 1 | 2022 | 375 | 0.150 |
Why?
|
Sensitivity and Specificity | 6 | 2017 | 14641 | 0.150 |
Why?
|
Subarachnoid Space | 1 | 2017 | 80 | 0.150 |
Why?
|
Female | 42 | 2022 | 390323 | 0.140 |
Why?
|
Syringomyelia | 1 | 2017 | 67 | 0.140 |
Why?
|
Carcinoma, Giant Cell | 1 | 2016 | 5 | 0.140 |
Why?
|
Spondylosis | 1 | 2017 | 85 | 0.140 |
Why?
|
Clavicle | 1 | 2019 | 224 | 0.140 |
Why?
|
Retrospective Studies | 14 | 2019 | 80168 | 0.130 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2017 | 195 | 0.130 |
Why?
|
Arnold-Chiari Malformation | 1 | 2017 | 158 | 0.130 |
Why?
|
Hospitalization | 1 | 2015 | 10652 | 0.130 |
Why?
|
Femur Head Necrosis | 1 | 2016 | 132 | 0.120 |
Why?
|
Fellowships and Scholarships | 1 | 2024 | 1115 | 0.120 |
Why?
|
Spiro Compounds | 1 | 2014 | 68 | 0.120 |
Why?
|
Forecasting | 1 | 2024 | 2923 | 0.120 |
Why?
|
Bone Diseases, Metabolic | 2 | 2016 | 409 | 0.120 |
Why?
|
Fractures, Bone | 2 | 2019 | 2040 | 0.120 |
Why?
|
Receptors, Opioid | 1 | 2014 | 145 | 0.120 |
Why?
|
Photons | 2 | 2016 | 581 | 0.120 |
Why?
|
Femur | 3 | 2022 | 1302 | 0.120 |
Why?
|
Interinstitutional Relations | 1 | 2015 | 236 | 0.120 |
Why?
|
Surgery, Computer-Assisted | 1 | 2022 | 1008 | 0.110 |
Why?
|
Aged, 80 and over | 11 | 2016 | 58683 | 0.110 |
Why?
|
Patient Positioning | 2 | 2016 | 327 | 0.110 |
Why?
|
Appointments and Schedules | 1 | 2017 | 441 | 0.110 |
Why?
|
Industry | 1 | 2015 | 361 | 0.110 |
Why?
|
Employee Performance Appraisal | 1 | 2013 | 86 | 0.110 |
Why?
|
Bone and Bones | 2 | 2016 | 2560 | 0.110 |
Why?
|
Child | 13 | 2021 | 79818 | 0.110 |
Why?
|
Aged | 20 | 2022 | 168218 | 0.100 |
Why?
|
Osteotomy | 1 | 1998 | 836 | 0.100 |
Why?
|
Adolescent | 13 | 2017 | 87892 | 0.100 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 7985 | 0.100 |
Why?
|
Decompression, Surgical | 1 | 2017 | 604 | 0.100 |
Why?
|
Joint Diseases | 1 | 2016 | 457 | 0.100 |
Why?
|
Knee Joint | 2 | 2022 | 1663 | 0.100 |
Why?
|
Electronic Health Records | 1 | 2009 | 4761 | 0.100 |
Why?
|
Back Pain | 2 | 2016 | 543 | 0.100 |
Why?
|
Postoperative Complications | 3 | 2017 | 15637 | 0.100 |
Why?
|
Administration, Oral | 4 | 2014 | 3991 | 0.100 |
Why?
|
Young Adult | 12 | 2017 | 58808 | 0.100 |
Why?
|
Chondroblastoma | 2 | 2009 | 48 | 0.100 |
Why?
|
Treatment Outcome | 11 | 2017 | 64378 | 0.100 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2359 | 0.100 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2022 | 1370 | 0.090 |
Why?
|
Sex Distribution | 1 | 2016 | 2284 | 0.090 |
Why?
|
Heart Rate | 1 | 2003 | 4166 | 0.090 |
Why?
|
Current Procedural Terminology | 1 | 2011 | 90 | 0.090 |
Why?
|
Public Opinion | 1 | 2014 | 482 | 0.090 |
Why?
|
Retreatment | 1 | 2012 | 596 | 0.090 |
Why?
|
Efficiency | 1 | 2013 | 477 | 0.090 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2010 | 55 | 0.090 |
Why?
|
Child, Preschool | 7 | 2017 | 42062 | 0.090 |
Why?
|
Glucosyltransferases | 1 | 2010 | 95 | 0.090 |
Why?
|
Medical Audit | 1 | 2011 | 452 | 0.090 |
Why?
|
Macrocyclic Compounds | 1 | 2010 | 67 | 0.090 |
Why?
|
Genes, MHC Class I | 1 | 2010 | 240 | 0.090 |
Why?
|
Viscera | 1 | 2010 | 138 | 0.090 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12951 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 843 | 0.080 |
Why?
|
HLA-B Antigens | 1 | 2010 | 331 | 0.080 |
Why?
|
Algorithms | 2 | 2012 | 13961 | 0.080 |
Why?
|
Small Molecule Libraries | 1 | 2014 | 724 | 0.080 |
Why?
|
Facial Pain | 1 | 2010 | 120 | 0.080 |
Why?
|
Injections, Epidural | 1 | 2010 | 200 | 0.080 |
Why?
|
Osteitis Fibrosa Cystica | 1 | 2008 | 11 | 0.080 |
Why?
|
Zygapophyseal Joint | 1 | 2010 | 128 | 0.080 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2010 | 311 | 0.080 |
Why?
|
United States | 6 | 2024 | 72136 | 0.080 |
Why?
|
Boston | 3 | 2015 | 9304 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2016 | 20055 | 0.080 |
Why?
|
Absorptiometry, Photon | 1 | 2014 | 1735 | 0.070 |
Why?
|
Communication | 2 | 2014 | 3846 | 0.070 |
Why?
|
Notochord | 1 | 2007 | 37 | 0.070 |
Why?
|
Ilium | 1 | 2008 | 154 | 0.070 |
Why?
|
Imidazoles | 2 | 2004 | 1179 | 0.070 |
Why?
|
Neoplasms | 1 | 2016 | 22032 | 0.070 |
Why?
|
Prospective Studies | 6 | 2018 | 54137 | 0.070 |
Why?
|
Muscle Strength | 1 | 2011 | 618 | 0.070 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2008 | 125 | 0.070 |
Why?
|
Injections, Intra-Articular | 1 | 2008 | 279 | 0.070 |
Why?
|
Inpatients | 1 | 2019 | 2551 | 0.070 |
Why?
|
Bone Cements | 1 | 2008 | 324 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2016 | 39059 | 0.070 |
Why?
|
Practice Guidelines as Topic | 3 | 2014 | 7378 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2685 | 0.070 |
Why?
|
Acetylene | 1 | 2006 | 7 | 0.070 |
Why?
|
Sarcoidosis | 1 | 2012 | 520 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 754 | 0.070 |
Why?
|
Internationality | 1 | 2012 | 1000 | 0.070 |
Why?
|
Dominance-Subordination | 1 | 2005 | 26 | 0.070 |
Why?
|
Chondroma | 2 | 2005 | 53 | 0.070 |
Why?
|
Femoral Neoplasms | 2 | 2003 | 82 | 0.070 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2010 | 620 | 0.060 |
Why?
|
Structure-Activity Relationship | 5 | 2014 | 3069 | 0.060 |
Why?
|
Tourniquets | 1 | 2006 | 107 | 0.060 |
Why?
|
Competitive Behavior | 1 | 2005 | 77 | 0.060 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 1214 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1254 | 0.060 |
Why?
|
Documentation | 1 | 2011 | 892 | 0.060 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2006 | 169 | 0.060 |
Why?
|
Calcaneus | 1 | 2006 | 142 | 0.060 |
Why?
|
Acetabulum | 1 | 2008 | 541 | 0.060 |
Why?
|
Malpractice | 1 | 2009 | 555 | 0.060 |
Why?
|
Computer Simulation | 2 | 2015 | 6201 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2014 | 2215 | 0.060 |
Why?
|
Software | 2 | 2010 | 4415 | 0.060 |
Why?
|
False Negative Reactions | 1 | 2005 | 573 | 0.060 |
Why?
|
Health Services Research | 1 | 2011 | 1812 | 0.060 |
Why?
|
Time Factors | 3 | 2016 | 39872 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2015 | 14490 | 0.060 |
Why?
|
Infant | 2 | 2016 | 36055 | 0.050 |
Why?
|
Quinazolines | 1 | 2010 | 1360 | 0.050 |
Why?
|
Artifacts | 1 | 2012 | 1897 | 0.050 |
Why?
|
Amides | 1 | 2006 | 447 | 0.050 |
Why?
|
Receptors, Corticotropin | 1 | 2003 | 24 | 0.050 |
Why?
|
Thiadiazoles | 1 | 2003 | 64 | 0.050 |
Why?
|
alpha-MSH | 1 | 2003 | 71 | 0.050 |
Why?
|
False Positive Reactions | 1 | 2005 | 956 | 0.050 |
Why?
|
GABA-A Receptor Agonists | 1 | 2002 | 86 | 0.050 |
Why?
|
Medical Errors | 1 | 2010 | 1255 | 0.050 |
Why?
|
Necrosis | 1 | 2006 | 1604 | 0.050 |
Why?
|
Prevalence | 3 | 2016 | 15651 | 0.050 |
Why?
|
Biocompatible Materials | 1 | 2010 | 1688 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4901 | 0.050 |
Why?
|
Bone Nails | 1 | 2022 | 218 | 0.050 |
Why?
|
Observer Variation | 2 | 2018 | 2600 | 0.040 |
Why?
|
Calcitriol | 1 | 2002 | 297 | 0.040 |
Why?
|
Enzymes | 1 | 2002 | 258 | 0.040 |
Why?
|
Primary Health Care | 1 | 2017 | 4652 | 0.040 |
Why?
|
Splenectomy | 1 | 2002 | 391 | 0.040 |
Why?
|
Logistic Models | 2 | 2012 | 13276 | 0.040 |
Why?
|
Massachusetts | 3 | 2009 | 8823 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 2 | 2006 | 3217 | 0.040 |
Why?
|
Celiac Disease | 1 | 2008 | 822 | 0.040 |
Why?
|
Diphosphonates | 1 | 2004 | 636 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2011 | 3446 | 0.040 |
Why?
|
Adenoviridae | 1 | 2003 | 1084 | 0.040 |
Why?
|
Human Growth Hormone | 1 | 2003 | 638 | 0.040 |
Why?
|
Kidney Neoplasms | 2 | 2006 | 4312 | 0.040 |
Why?
|
Piperidines | 1 | 2007 | 1639 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4048 | 0.040 |
Why?
|
Pyridines | 2 | 2007 | 2859 | 0.040 |
Why?
|
Pyridones | 1 | 2002 | 784 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2016 | 13245 | 0.030 |
Why?
|
Palliative Care | 1 | 2012 | 3570 | 0.030 |
Why?
|
Shoulder Joint | 1 | 2003 | 732 | 0.030 |
Why?
|
Rats | 6 | 2014 | 23679 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2017 | 216 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2003 | 1165 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6457 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25956 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 414 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2005 | 3759 | 0.030 |
Why?
|
Disease Progression | 4 | 2017 | 13468 | 0.030 |
Why?
|
Consensus | 2 | 2016 | 3099 | 0.030 |
Why?
|
Opioid Peptides | 1 | 2014 | 37 | 0.030 |
Why?
|
Kyphosis | 1 | 2017 | 237 | 0.030 |
Why?
|
Utilization Review | 1 | 2016 | 382 | 0.030 |
Why?
|
Feeding Behavior | 2 | 2005 | 3184 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8530 | 0.030 |
Why?
|
Lipids | 1 | 2005 | 3326 | 0.030 |
Why?
|
Body Composition | 1 | 2003 | 2416 | 0.030 |
Why?
|
Contrast Media | 2 | 2017 | 5298 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2007 | 4018 | 0.030 |
Why?
|
Incidence | 1 | 2012 | 21272 | 0.030 |
Why?
|
Naltrexone | 2 | 2007 | 317 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2005 | 2889 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2003 | 3380 | 0.030 |
Why?
|
Pilot Projects | 1 | 2006 | 8553 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6850 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6520 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3867 | 0.030 |
Why?
|
Demography | 1 | 2017 | 1651 | 0.030 |
Why?
|
Rats, Long-Evans | 2 | 2003 | 378 | 0.020 |
Why?
|
Cohort Studies | 2 | 2011 | 41256 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 2 | 2003 | 462 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2002 | 6293 | 0.020 |
Why?
|
Narcotic Antagonists | 2 | 2007 | 583 | 0.020 |
Why?
|
Limb Salvage | 1 | 2013 | 464 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6821 | 0.020 |
Why?
|
Crohn Disease | 1 | 2003 | 2275 | 0.020 |
Why?
|
Efficiency, Organizational | 1 | 2015 | 696 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 584 | 0.020 |
Why?
|
Research Design | 1 | 2006 | 6157 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 147 | 0.020 |
Why?
|
Physicians, Primary Care | 1 | 2017 | 624 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 225 | 0.020 |
Why?
|
Cryopreservation | 1 | 2015 | 717 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4902 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2010 | 121 | 0.020 |
Why?
|
HIV Antigens | 1 | 2010 | 325 | 0.020 |
Why?
|
Motor Activity | 2 | 2014 | 2685 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2016 | 2896 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2013 | 1791 | 0.020 |
Why?
|
Melanoma | 2 | 2004 | 5691 | 0.020 |
Why?
|
Coccyx | 1 | 2007 | 13 | 0.020 |
Why?
|
Reoperation | 1 | 1998 | 4282 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2016 | 1659 | 0.020 |
Why?
|
Protein Binding | 2 | 2014 | 9311 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10748 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2013 | 1386 | 0.020 |
Why?
|
Systems Integration | 1 | 2009 | 426 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6354 | 0.020 |
Why?
|
Research | 1 | 2015 | 1976 | 0.020 |
Why?
|
Hypocalcemia | 1 | 2008 | 199 | 0.020 |
Why?
|
Income | 1 | 2015 | 1872 | 0.020 |
Why?
|
New York | 1 | 2009 | 874 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2007 | 412 | 0.020 |
Why?
|
Maprotiline | 1 | 2005 | 3 | 0.020 |
Why?
|
Pain Measurement | 1 | 2016 | 3527 | 0.020 |
Why?
|
Information Dissemination | 1 | 2014 | 1129 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2010 | 1792 | 0.020 |
Why?
|
Pelvic Bones | 1 | 2008 | 270 | 0.020 |
Why?
|
Imipramine | 1 | 2005 | 98 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6493 | 0.020 |
Why?
|
Image Enhancement | 1 | 2016 | 2880 | 0.020 |
Why?
|
Drinking | 1 | 2007 | 199 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1196 | 0.020 |
Why?
|
Steroids | 1 | 2010 | 926 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2013 | 3527 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5199 | 0.020 |
Why?
|
Drug Tolerance | 1 | 2007 | 367 | 0.020 |
Why?
|
Risk Factors | 1 | 2012 | 73809 | 0.020 |
Why?
|
Amino Acids | 1 | 2010 | 1713 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3671 | 0.010 |
Why?
|
Remission, Spontaneous | 1 | 2005 | 384 | 0.010 |
Why?
|
Length of Stay | 1 | 1998 | 6439 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1780 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2004 | 5797 | 0.010 |
Why?
|
Haplotypes | 1 | 2010 | 2764 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 17275 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4839 | 0.010 |
Why?
|
Thigh | 1 | 2005 | 240 | 0.010 |
Why?
|
Mesna | 1 | 2003 | 62 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7818 | 0.010 |
Why?
|
CHO Cells | 1 | 2006 | 1389 | 0.010 |
Why?
|
Chlordiazepoxide | 1 | 2002 | 42 | 0.010 |
Why?
|
Ifosfamide | 1 | 2003 | 232 | 0.010 |
Why?
|
Flumazenil | 1 | 2002 | 84 | 0.010 |
Why?
|
Pentylenetetrazole | 1 | 2002 | 71 | 0.010 |
Why?
|
Convulsants | 1 | 2002 | 70 | 0.010 |
Why?
|
Protein Conformation | 1 | 2010 | 3966 | 0.010 |
Why?
|
Infusions, Parenteral | 1 | 2003 | 398 | 0.010 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2005 | 489 | 0.010 |
Why?
|
GABA Modulators | 1 | 2002 | 109 | 0.010 |
Why?
|
Animals | 7 | 2014 | 167768 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11709 | 0.010 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2003 | 128 | 0.010 |
Why?
|
Cricetinae | 1 | 2006 | 2426 | 0.010 |
Why?
|
Shoulder Pain | 1 | 2003 | 148 | 0.010 |
Why?
|
Risk Assessment | 2 | 2015 | 23884 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7403 | 0.010 |
Why?
|
Saimiri | 1 | 2002 | 334 | 0.010 |
Why?
|
Lorazepam | 1 | 2002 | 154 | 0.010 |
Why?
|
Fluoxetine | 1 | 2005 | 733 | 0.010 |
Why?
|
Central Nervous System Depressants | 1 | 2002 | 164 | 0.010 |
Why?
|
Molecular Structure | 1 | 2006 | 1866 | 0.010 |
Why?
|
Pain | 2 | 2008 | 5065 | 0.010 |
Why?
|
Viral Load | 1 | 2010 | 3321 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6036 | 0.010 |
Why?
|
Medicine | 1 | 2009 | 942 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18119 | 0.010 |
Why?
|
Nephrectomy | 1 | 2006 | 1016 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5410 | 0.010 |
Why?
|
Dacarbazine | 1 | 2003 | 559 | 0.010 |
Why?
|
Medical Records Systems, Computerized | 1 | 2006 | 1190 | 0.010 |
Why?
|
Anxiety | 1 | 2014 | 4539 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7980 | 0.010 |
Why?
|
Seizures | 2 | 2002 | 2919 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6895 | 0.010 |
Why?
|
Societies, Medical | 1 | 2011 | 3891 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 2003 | 1032 | 0.010 |
Why?
|
Vitamin D Deficiency | 1 | 2008 | 1377 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2010 | 3047 | 0.010 |
Why?
|
Receptors, GABA-A | 1 | 2002 | 621 | 0.010 |
Why?
|
Conscious Sedation | 1 | 2002 | 529 | 0.010 |
Why?
|
Postural Balance | 1 | 2002 | 617 | 0.010 |
Why?
|
Drug Interactions | 1 | 2002 | 1414 | 0.010 |
Why?
|
Mice | 4 | 2006 | 81101 | 0.010 |
Why?
|
Benzimidazoles | 1 | 2002 | 855 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2010 | 4549 | 0.010 |
Why?
|
Doxorubicin | 1 | 2003 | 2209 | 0.010 |
Why?
|
Fasting | 1 | 2003 | 1599 | 0.010 |
Why?
|
Radiotherapy | 1 | 2003 | 1504 | 0.010 |
Why?
|
Ethanol | 1 | 2002 | 1323 | 0.010 |
Why?
|
Acute Disease | 1 | 2007 | 7225 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2009 | 12096 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6127 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2002 | 1866 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15785 | 0.010 |
Why?
|
Survival Analysis | 1 | 2006 | 10112 | 0.010 |
Why?
|
Testosterone | 1 | 2003 | 2471 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2003 | 2821 | 0.010 |
Why?
|
Chronic Disease | 1 | 2007 | 9267 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2003 | 3299 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 29557 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12604 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15773 | 0.010 |
Why?
|
Computational Biology | 1 | 2003 | 3502 | 0.010 |
Why?
|
Survival Rate | 1 | 2004 | 12721 | 0.010 |
Why?
|
Sleep | 1 | 2002 | 4744 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 2002 | 5759 | 0.000 |
Why?
|